Literature DB >> 25545344

Direct infection of primary salivary gland epithelial cells by human T lymphotropic virus type I in patients with Sjögren's syndrome.

Hideki Nakamura1, Yoshiko Takahashi, Tomomi Yamamoto-Fukuda, Yoshiro Horai, Yoshikazu Nakashima, Kazuhiko Arima, Tatsufumi Nakamura, Takehiko Koji, Atsushi Kawakami.   

Abstract

OBJECTIVE: To investigate whether human T lymphotropic virus type I (HTLV-I) directly infects salivary gland epithelial cells (SGECs) and induces the niche of the salivary glands in patients with Sjögren's syndrome (SS).
METHODS: SGECs were cultured with the HTLV-I-producing CD4+ T cell line HCT-5 or with Jurkat cells. Antibody arrays, immunofluorescence analysis, and enzyme-linked immunosorbent assay (ELISA) were used to determine the profiles of inflammation-related molecules, and the profiles of apoptosis-related molecules were determined by antibody array and immunofluorescence analysis. The presence of HTLV-I-related molecules was assessed by immunofluorescence analysis and in situ polymerase chain reaction. Apoptosis of SGECs was evaluated by TUNEL staining.
RESULTS: Among the SGECs, 7.8 ± 1.3% (mean ± SD) were positive for HTLV-I-related proteins after 96-hour coculture with HCT-5 cells. Nuclear NF-κB p65 was also detected in 10% of the SGECs. The presence of HTLV-I proviral DNA in SGECs after coculture with HCT-5 cells was detected by in situ polymerase chain reaction. After coculture of SGECs with HCT-5, the expression of cytokines and chemokines, including soluble intercellular adhesion molecule 1, RANTES, and interferon γ-induced protein 10 kd (IP-10/CXCL10) was increased in a time-dependent manner. The expression of proapoptotic molecules (e.g., cytochrome c and Fas) and antiapoptotic molecules (e.g., Bcl-2, Heme oxygenase 2, and Hsp27) was increased in the SGECs cocultured with HCT-5, showing that apoptosis of SGECs was not detected after coculture with HCT-5 or Jurkat cells.
CONCLUSION: HTLV-I is thought to infect SGECs and alter their cellular functions. These changes may induce the niche of SS and contribute to the development of SS in anti-HTLV-I antibody-positive individuals.
Copyright © 2015 by the American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25545344     DOI: 10.1002/art.39009

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN: 2326-5191            Impact factor:   10.995


  12 in total

1.  HTLV-1 targets human placental trophoblasts in seropositive pregnant women.

Authors:  Kenta Tezuka; Naoki Fuchi; Kazu Okuma; Takashi Tsukiyama; Shoko Miura; Yuri Hasegawa; Ai Nagata; Nahoko Komatsu; Hiroo Hasegawa; Daisuke Sasaki; Eita Sasaki; Takuo Mizukami; Madoka Kuramitsu; Sahoko Matsuoka; Katsunori Yanagihara; Kiyonori Miura; Isao Hamaguchi
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

2.  Unique glandular ex-vivo Th1 and Th17 receptor motifs in Sjögren's syndrome patients using single-cell analysis.

Authors:  Alexandria Voigt; Katherine Bohn; Sukesh Sukumaran; Carol M Stewart; Indraneel Bhattacharya; Cuong Q Nguyen
Journal:  Clin Immunol       Date:  2018-04-19       Impact factor: 3.969

3.  Uncovering potential single nucleotide polymorphisms, copy number variations and related signaling pathways in primary Sjogren's syndrome.

Authors:  Xuan Qi; Xi-Qin Wang; Lu Jin; Li-Xia Gao; Hui-Fang Guo
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

Review 4.  The Role of Interferons in the Pathogenesis of Sjögren's Syndrome and Future Therapeutic Perspectives.

Authors:  Nicoletta Del Papa; Antonina Minniti; Maurizio Lorini; Vincenzo Carbonelli; Wanda Maglione; Francesca Pignataro; Nicola Montano; Roberto Caporali; Claudio Vitali
Journal:  Biomolecules       Date:  2021-02-09

5.  CP-25 alleviates antigen-induced experimental Sjögren's syndrome in mice by inhibiting JAK1-STAT1/2-CXCL13 signaling and interfering with B-cell migration.

Authors:  Huaxun Wu; Xiaoyun Chen; Fang Gu; Pengying Zhang; Shixia Xu; Qi Liu; Qiaolin Zhang; Xinming Wang; Chun Wang; Heinrich Körner; Wei Wei
Journal:  Lab Invest       Date:  2020-07-03       Impact factor: 5.502

Review 6.  HTLV-1, Immune Response and Autoimmunity.

Authors:  Juarez A S Quaresma; Gilberto T Yoshikawa; Roberta V L Koyama; George A S Dias; Satomi Fujihara; Hellen T Fuzii
Journal:  Viruses       Date:  2015-12-24       Impact factor: 5.048

7.  Tumor necrosis factor alpha inhibitors have no effect on a human T-lymphotropic virus type-I (HTLV-I)-infected cell line from patients with HTLV-I-associated myelopathy.

Authors:  Shoichi Fukui; Hideki Nakamura; Yoshiko Takahashi; Naoki Iwamoto; Hiroo Hasegawa; Katsunori Yanagihara; Tatsufumi Nakamura; Akihiko Okayama; Atsushi Kawakami
Journal:  BMC Immunol       Date:  2017-02-03       Impact factor: 3.615

8.  Reevaluation for clinical manifestations of HTLV-I-seropositive patients with Sjögren's syndrome.

Authors:  Hideki Nakamura; Toshimasa Shimizu; Yukinori Takagi; Yoshiko Takahashi; Yoshiro Horai; Yoshikazu Nakashima; Shuntaro Sato; Hirokazu Shiraishi; Tatsufumi Nakamura; Junya Fukuoka; Takashi Nakamura; Atsushi Kawakami
Journal:  BMC Musculoskelet Disord       Date:  2015-11-04       Impact factor: 2.362

Review 9.  Role of Viral Infections in the Pathogenesis of Sjögren's Syndrome: Different Characteristics of Epstein-Barr Virus and HTLV-1.

Authors:  Hideki Nakamura; Toshimasa Shimizu; Atsushi Kawakami
Journal:  J Clin Med       Date:  2020-05-13       Impact factor: 4.241

Review 10.  Does HTLV-1 Infection Show Phenotypes Found in Sjögren's Syndrome?

Authors:  Hideki Nakamura; Masako Tsukamoto; Yosuke Nagasawa; Noboru Kitamura; Toshimasa Shimizu; Atsushi Kawakami; Kinya Nagata; Masami Takei
Journal:  Viruses       Date:  2022-01-06       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.